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Enterotoxigenic Escherichia coli (ETEC) infection is common in calves. Egg yolk antibodies (IgY) have 
been used to treat gastrointestinal infectious diseases. This study aimed to characterize IgY against 
bovine ETEC and to evaluate its effects on bovine intestinal cell culture challenged with a bovine ETEC 
strain. IgY was isolated from the egg yolks of hens immunized with ETEC. The characteristics of IgY 
were determined by Bradford, ELISA, gel electrophoresis and immunoblotting. Significant differences in 
anti-ETEC activity between anti-ETEC IgY and non-specific IgY were found in lyophilized fractions. In 
the bacterial growth assay, anti-ETEC IgY (40 mg/mL) showed growth inhibition of ETEC after 2 h of 
incubation (p<0.05). The difference in bacterial growth between anti-ETEC IgY and non-specific IgY 
groups was 0.51 log CFU/ml after an 8 h incubation (p<0.05). The bacterial adhesion assay indicated 
that anti-ETEC IgY (40 mg/ml) significantly decreased the adhesion of ETEC
 
to bovine intestinal 
epithelial cells within 4 h (about 1.36 log units compared with the control group; p<0.05). This study 
demonstrates that anti-ETEC IgY inhibits the growth and adherence of ETEC
 
to bovine intestinal cells 
and is a potential alternative to traditional treatments of E. coli infections. 
 
Key words: Immunoglobulin Y (IgY), neonatal calf diarrhea, enterotoxigenic Escherichia coli, bacterial 
adherence, bacterial growth. 
 
 
INTRODUCTION 
 
Neonatal calf diarrhea is a leading cause of morbidity and 
mortality in pre-weaned dairy calves. It is estimated that 
diarrhea accounts for greater than 50% of pre-weaned 
calf deaths (USDA, 2008). Thus, research about 
prevention and therapies for this disease is certainly 
needed. 
Pathogenic  Escherichia  coli  (E.  coli)  are  one  of  the  
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most common and serious bacterial causes of neonatal 
calf diarrhea. Enterotoxigenic Escherichia coli (ETEC) 
produce, at least, one member of the two defined groups 
of enterotoxins: termostable (ST) and termolabile (LT). 
One of the main colonization factors or surface proteins 
described in pathogenic bovine Escherichia coli is F17 
fimbriae (Nguyen et al., 2011).  
Considering the present awareness of the problems 
associated with the excessive use of antibiotics and the 
lack of success of specific vaccines for the post-weaned 
calf, alternatives for preventing infectious diarrheal 
diseases are required. 
 
 
 
 
Egg yolk immunoglobulin (IgY) technology is a highly 
innovative and growing biotechnology area, offering 
numerous advantages including low cost, effectiveness, 
efficiency and the minimization of animal suffering (Pauly 
et al., 2009).  
Previous studies have observed that the success of IgY 
is associated with its capacity to block bacterial binding to 
the host cell (Cook and Trott, 2010). While there are 
some published reports that IgY inhibited the adhesion of 
E. coli to piglet intestinal cells (Deneke et al., 1984; 
Jungling et al., 1991; Yokoyama et al., 1992) and 
intestinal pig mucus (Jin et al., 1998), to the best of our 
knowledge, no studies have been done in bovine 
intestinal cells.  
Therefore, the aim of the present study was to 
characterize anti-ETEC IgY and evaluate its effects on 
bovine intestinal cells challenged with a bovine ETEC 
strain. 
 
 
MATERIALS AND METHODS 
 
Bacterial strain and culture conditions 
 
The ETEC strain used in this study was isolated from a neonatal 
calf belonging to a dairy farm in Córdoba Province (Argentina) and 
cultured on MacConkey agar (Britania®, Argentina) at 37°C for 48 
h. The strain was F17
+
 and STa
+
, as indicated by molecular 
analysis of PCR (Picco et al., 2011). The presence of F17 antigen 
was assayed with bacteria grown on Minca solid media (Guinée et 
al., 1977) by slide agglutination using specifically adsorbed 
antiserum. 
 
 
Animals 
 
Twelve (12) Lohmann Brown-Classic hens (19-week-old) were 
obtained from a poultry farm (Cabaña Avicola Jorju SACIFyA, 
Buenos Aires-Argentina). The animals were kept in individual cages 
with food and water ad libitum, without contact with any other 
animals. The food was based on a balanced food for laying hens 
(Nutriarte, Córdoba-Argentina). A cycle of light/dark of 16/8 h was 
used. The room temperature was 20 ± 2°C and relative humidity 
between 55 to 60%. 
This study received formal approval from the ethics committee of 
the Universidad Nacional de Río Cuarto. In order to guarantee a 
safe, correct and careful use and handling of experimental animals, 
the investigators proceeded according to the ethical guidelines of 
animal welfare committee (Olfert et al., 1993). 
 
 
Immunization of hens 
 
Eight hens were immunized to obtain anti-ETEC IgY loaded eggs. 
To elaborate the immunogen, bacteria were inactivated with 0.5% 
formaldehyde and incubated overnight 37°C. After incubation, 
bacteria were pelleted by centrifugation (2,500 rpm for 5 min) and 
washed 3 times with PBS.  A total amount of 1 ml of inactivated 
bovine ETEC whole cells (1 x 10
9 
CFU/ml) was mixed with 7% 
aluminum hydroxide and injected intramuscularly in breast muscles. 
The remaining four hens only received 1 ml sterile PBS with 7% 
aluminum hydroxide to obtain non-specific IgY. Booster 
immunizations were given at 2 and 4 weeks after the initial 
immunization in the same manner. Eggs were  collected  daily  from  
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day 40 since 175 post-first immunization and stored at 4°C until 
used. 
 
 
Purification of yolk antibodies 
 
The water-soluble fraction (WSF) containing IgY was prepared from 
egg yolk using the water dilution method (WD) developed by Akita 
and Nakai (1992) with minor modifications. Briefly, egg yolk was 
physically separated from egg white and rolled on paper towels to 
remove the rest of adhered egg white. The membrane was 
punched and the yolk was allowed to flow into a graduated cylinder 
without the membrane. The egg yolk was mixed gently with six 
volumes of cold acidified distilled water (pH 2.5 adjusted with 0.1 M 
HCl). After mixing well, the mixture was adjusted to a pH ranging 
from 5.0 to 5.2 and incubated at 4°C for 12 h. The WSF was 
obtained by centrifugation (Beckman Coulter Avanti J-25) at 12,000 
x g and 4°C for 20 min, the supernatant was considered as WSF 
and stored at -20°C, until use. 
The avian immunoglobulins were precipitated by sodium sulfate 
as described previously for purification of IgY (Wooley and Landon, 
1995). Sodium sulfate was added at a final concentration of 20% 
(w/v) and stirred for 20 min at room temperature and then the 
mixture was centrifuged at 2,000 x g for 30 min at 4°C. Finally, the 
pellet was resuspended in PBS to initial yolk volume and dialyzed 
against 0.1% NaCl solution. 
After dialysis, IgY samples were frozen at -20°C in plastic 
containers and freeze-dried for 48 h (Labconco Stoppering Try 
Dryer lyophilizer). 
 
 
Electrophoresis and western blot analysis 
 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was carried out according to Laemmli (1970). The gels were 
stained with Coomassie Brillant Blue R-250 (Ultra-Pure
TM
, Gibco 
BRL). Wide molecular weight marker ranging from 6.5 to 205 kDa 
(Sigma

, M-4038) was used as standard. The gel was 
electrophoretically transferred to polyvinylidene difluoride [(PVDF) 
(Millipore Immobilon
TM
)] membranes. The membranes were 
incubated with horseradish peroxidase (HRP)-conjugated rabbit 
anti-chicken antibody (Sigma

, A9046) and placed in peroxidase 
chromogenic substrate solution (3,3’-diaminobenzidine tablets, 
Sigma

 D4418) and then rinsed in excess distilled water to stop the 
color development.  
 
 
Protein quantification 
 
The protein concentration was determined at 595 nm by Bradford 
method (Bradford, 1976) with a spectrophotometer (Jasco” modelo 
V-630 Bio).  
 
 
Total IgY concentration 
 
Total concentration of IgY was evaluated by ELISA, it was 
performed as described by Sunwoo et al. (2012) with modifications 
carried out by our group. The wells of microtiter plate (Costar, 
Corning, N.Y., U.S.A.) were coated with 50 µL of serial dilutions of 
purified chicken IgG (1 mg/ml) (Sigma

, I-4881) in carbonate-
bicarbonate buffer to prepare a standard curve. In the same plate, 
anti-ETEC IgY and non-specific IgY powders were reconstituted (2 
mg/ml) and diluted in carbonate-bicarbonate buffer (0.05 M, pH 
9.6). The plate was coated with these preparations and incubated 
over night at 4°C. The plate was washed 4 times with PBS 
containing 0.05% Tween 20 between each step. After washing, 150  
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µL of a 5% (w/v) non-fat dry milk were added to each well and 
incubated at 37 °C in humid chamber for 1 h. Rabbit anti-chicken 
IgG conjugated with horseradish peroxidase (diluted 1:1000 in PBS 
with 2% of non-fat dry milk) (Sigma

, A-9046) was added to each 
well and incubated at 37 °C for 2 h in humid chamber. After 
washing,  100 µl of freshly prepared substrate solution of 3,30,5,50-
tetramethylbenzidine (TMB, Sigma, T-3405) in 0.05 M phosphate 
citrate buffer (pH 5.0) (Sigma Chemical Co.) containing 6 µl of 30% 
hydrogen peroxide was added. (Sigma Chemical Co.). The reaction 
was stopped by 3 M H2SO4 and measured in an ELISA reader at 
450 nm (Biolatin CPD Reader 212). 
 
 
Specific IgY determination 
 
Anti-ETEC activity was  done using the ELISA method developed 
by our research group. Briefly, plates were coated with 50 μl of a 
suspension of concentrated and heat-inactivated ETEC strain 
(>10
10
 UFC/ml) in carbonate-bicarbonate buffer (0.05 M, pH 9.6) 
and incubated overnight at 4°C. Non-specific protein-binding sites 
were blocked with PBS-T (pH 7.2) containing 5% non-fat milk. 
Serial dilutions of anti-ETEC IgY and control IgY (1/10
1
 to 1/10
15
) in 
PBS-T with 2% non-fat milk were then incubated at 37°C for 1 h in 
humid chamber. After washing with PBS-T, the plates were 
incubated for 1 h in humid chamber with 150 µl of rabbit anti-
chicken IgG horseradish peroxidase-conjugated (diluted 1:1000 in 
PBS with 2% non-fat dry milk). After washing, the TMB solution was 
added and the reactions were stopped with H2SO4 (3 M). The 
absorbance was read at 450 nm (Biolatin CPD Reader 212). The 
titles of specific anti-ETEC IgY and control IgY were determined.  
 
 
Bacterial growth assay 
 
The bacterial growth assay was performed as described by Amaral 
et al. (2008). Lyophilized IgY was resuspended in 2 ml of brain 
hearth infusion (BHI), the solutions were filtered (0.22 μm) and 
mixed with 2 ml of bacterial suspension. The growth assay was 
carried out with four groups: control 1 (ETEC - 1.35 CFU/ml), 
control 2 (ETEC - 1.35 CFU/ml + non specific IgY- 40 mg/ml), 
treatment 1 (ETEC - 1.35 CFU/ml + anti-ETEC IgY 20 mg/ml) and 
treatment 2 (ETEC - 1.35 CFU/ml + anti-ETEC IgY 40 mg/ml). The 
cultures were incubated for 8 h at 37°C. 
After 0, 2, 4, 6, and 8 h, an aliquot of each culture was serially 
diluted in BHI and 100 μl were plated onto MacConkey Agar 
(Britania Argentina). After overnight incubation, the colonies were 
counted and their growth curves plotted.  
 
 
Isolation of bovine intestinal cells 
 
Intestinal fragments of proximal region of jejunum from adult 
animals were obtained from a local slaughterhouse. After several 
washes in warm (37°C) divalent ion free PBS, fragments were 
washed in warm PBS supplemented with 1% antibiotic-antimycotic 
solution (Gibco), 2.7 mg/ml D-glucose, and 4 mM L-glutamine and 
transported within 30 min to the laboratory.  
For the isolation of bovine intestinal cells, the distended intestinal 
sac method described previously in pigs (Fan et al., 2001) with 
minor modifications was used. Briefly, 20 cm of proximal small 
intestinal segment was dissected and incubated with preincubation 
buffer (27 mM sodium citrate, 0.2 mM, phenylmethanesulfonyl 
fluoride (PMSF) and 0.5 mM dithiothreitol (DTT), pH 7.4) at 37°C for 
15 min. After preincubation, the segment was incubated with 
isolation buffer (1.5 mM Na2-EDTA, 0.2 mM PMSF, 0.5 mM DTT, 
and 5 mM D-glucose, at 37°C for either 20 or 30 min). After 
incubation, the content of the segment, including buffer and isolated 
cells, were  collected  into  a  15-ml  conical  centrifuge  tubes.  This  
 
 
 
 
procedure was repeated 6 times to yield 6 “cell fractions” 
(designated F1 through F6). Each of the first three cell fractions (F1 
to F3) was collected after a separate 20 min incubation, whereas 
each of the last three fractions (F4 to F6) was collected after a 
separate 30 min incubation. The last cell fraction were washed 
twice as follows: was centrifuged at 400 x g for 4 min at 4°C, the 
supernatant discarded, and the cell pellet was dispersed with D-
MEM supplemented with 1 ng/ml Epidermal Growth Factor, 1 μg/ml 
insulin, 1% Glutamax (Gibco®), 1% Antibiotic-Antimycotic solution 
and 10% FBS. Microphotographs of cells were taken using an 
inverted microscope (Nikon, Eclipse TS100) and a camera (Zeiss, 
Axiocam ERc5s). 
 
 
Bacterial adhesion assay 
 
Approximately 5 x 10
5
 bovine intestinal cells were seeded in 24-well 
plates, grown overnight in Williams E medium and infected statically 
overnight with 5 ml of bovine ETEC culture (1 x 10
8
 CFU/ml)  
(control 1 Group). Infected bovine intestinal cells were incubated for 
4 h in 5% CO2 at 37°C. For the treatment groups, ETEC was 
previously incubated for 2 h with anti-ETEC IgY (20 and 40 mg/ml, 
treatment 1 and 2 respectively). For the control 2 group, ETEC was 
previously incubated for 2 h with non-specific IgY (40 mg/ml). The 
supernatants were removed and the cells were washed with PBS. 
Then, 1% Triton X-100 was added for 20 mins for bacterial 
liberation. The bacterial suspension was serially diluted, and plated 
on MacConkey agar to count CFUs.  
 
 
Statistical analyses 
 
Statistical analyses were performed using Infostat software (Grupo 
Infostat/FCA, 1998). Data were represented as means ± standard 
deviation (SD). Differences were considered significant at the level 
of p<0.05. Student’s t-test was applied to detect differences in 
protein and IgY concentration between anti-ETEC IgY and non-
specific IgY groups. In the bacterial growth assay, levels of 
significance were evaluated by one-way ANOVA followed by 
Tukey´s test and the least significant difference test for multiple 
comparisons. In the adhesion assay, the geometric mean number 
of CFU log in each group was compared with a non parametric 
Kruskal-Wallis test.  
 
 
RESULTS 
 
Electrophoresis and western blot analysis of WSF 
 
The WD method was effective in isolating IgY from egg 
yolks as documented by SDS-PAGE and Western 
blotting (Figure 1 A and B). The IgY precipitation with 
sodium sulfate was useful to reduce impurity levels in 
preparations. The results show there are two main 
subunits, in lanes 1 and 2 (Figure 1B), that represent the 
heavy and light chains of IgY. 
 
 
Concentrations of protein, total IgY and specific IgY 
in IgY powder 
 
Protein and total IgY concentration of anti-ETEC IgY was 
found to be similar to those obtained in the sample of 
non-specific  IgY.  However,  the  specific  IgY   titre   was  
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Figure 1. A- SDS-PAGE pattern of IgY purified by two steps. Reducing condition of SDS-15 % PAGE. 
Lanes: (M) wide molecular size marker; (1) fraction collected from Na2SO4 precipitation; (2) fraction 
collected from WSF; (3) standard IgY (Sigma). B- Western blot analysis of IgY fractions. Lanes: (1) 
fraction collected from sodium sulfate precipitation; (2) fraction collected from WSF; (3) standard IgY. The 
arrows indicate the heavy chain (HC) and light chain (LC) of IgY. 
 
 
 
Table 1. The concentrations of protein and total IgY, and specific IgY titre in IgY 
powder prepared from the WSF containing ETEC-specific or non-specific IgY. 
 
IgY powder Protein (mg/g) Total IgY (mg/g) Specific IgY (titre) 
Anti-ETEC 686.2 ± 58.6 195.3 ± 1.7* 1:100,000* 
Non-specific 556.1 ± 42.4 114.2 ± 3.4 1:1,000 
 
The values in each column are the average of three different assays. Different 
*Indicate significant difference (p<0.05) between both groups. 
 
 
 
1/1,000 and 1/100,000 for non-specific and anti-ETEC 
IgY. Both total concentration and specific titre of IgY were 
determined by an ELISA developed by our group (Table 
1).  
 
 
Bacterial growth assay 
 
As shown in Figure 2, treatment 2 (anti-ETEC IgY-20 
mg/ml) showed significant (p<0.05) inhibition of ETEC 
growth after 2 h of incubation compared with the control 1 
group. Cell counts of the treatment 2 group and control 1 
group rose by 0.26 log CFU/ml and 1.14 log CFU/ml, 
respectively, during 2 to 6 h of incubation. The highest 
inhibition was found at 8 h with treatment 2 with a 1.24 
log reduction of CFU/ml compared with the control 1 
group. 
Isolation of bovine intestinal cells 
 
The sequential isolation method allowed the efficient 
isolation of morphologically identifiable intestinal epithelial 
cells. In the last fraction, this method approximately 
yielded 1.2 x 10
7
 cells/ml. These cells had mainly 
columnar and spherical morphology (Figure 3). At least 
95% of cells were viable at the time of plating as 
determined by trypan blue exclusion method. 
 
 
Bacterial adhesion assay 
 
The bacterial adhesion assay shows that treatment group 
significantly reduced the CFU number of ETEC adhered 
to the intestinal bovine cells compared with Control 1 
group (5.48 ± 0.15 vs. 6.84 ± 0.09, p<0.05).  It  should  be  
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7.64 
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9.11 
9.59 
Time (h)  
 
Figure 2. Effect of IgY on the growth of ETEC in BHI broth. CFUs were measured in triplicate by the 
spread plate method on Mac Conkey Agar. Values are the mean ± SD (n=3). *p<0.05, as compared 
with corresponding treatment in the control 1 group. 
 
 
 
 
 
Figure 3. Micrograph of confluent monolayer of bovine 
intestinal epithelial cells after 2 days in culture. Barr = 100 µm. 
 
 
 
noted that control 2 group also significantly reduced the 
adherence of ETEC, however, the rate of inhibition was 
lower than that of the treatment group (Figure 4). 
 
 
DISCUSSION 
 
Although an effective protection against enteric pathogens  
has been obtained with the use of egg yolk antibodies in 
mice, pigs and calves, the in vitro evaluation of IgY 
effects on intestinal primary culture, as performed in this 
study, has not received much attention so far.  
The WD method was showed to be simple, rapid and 
inexpensive and it does not require the use of chemicals, 
thus we suggest its use in future purifications of specific 
IgY. Akita and Nakai (1993) compared  different  methods  
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Figure 4. Effect of IgY on the adherence of ETEC to bovine intestinal cells. CFUs were measured 
in triplicate by the spread plate method on MacConkey agar. Values are the mean ± SD (n=3). 
Different letters indicate significant difference (p<0.05). 
 
 
 
for IgY purification and WD was found superior in terms 
of ease of use and large scale production of IgY. Isolation 
of IgY with Polyethylene glycol has been described 
recently as another effective method to obtain chicken 
egg yolk antibodies (Meenatchisundaram and Michael, 
2011; Pauly et al., 2011). Previous studies evaluated the 
efficacy of immune yolk and semi purified IgY to protect 
the infectious bursal disease in infected birds and 
showed that concentrated egg immune yolk can give full 
protection. However, when it is purified by chemical 
methods, it does not give full protection (Farooq et al., 
2012). Addition of salts, such as ammonium or sodium 
sulfate, causes precipitation of mammals IgG. 
Ammonium sulfate has been used in previous studies to 
precipitate IgY (Trott et al., 2009; Zhen et al., 2008). In 
this study, the IgY was extracted from egg yolk with WD 
method and further precipitated with sodium sulfate. 
SDS-PAGE shows a reduce in the levels of impurities at 
the IgY preparations. Western blot revealed no 
alterations in its biological integrity. The freeze drying 
process seems to be a suitable method to conserve IgY 
and to preserve its biological stability. Also, Fu et al. 
(2006) reports no significant reduction in reactive activity 
and good thermal stability after freeze drying process. 
Protein and total IgY concentrations of non-specific IgY 
and anti-ETEC IgY powders were similar. In contrast, 
Mahdavi et al. (2010), found that total IgY concentration 
and IgY purity  of specific IgY powder were approximately 
30% higher than the non-specific IgY powder (p<0.05). 
Specific IgY titre in the non-specific IgY powder was 
significantly lower than that in specific IgY powder, as 
expected. The ELISA performed in this study appears to 
be a sensitive technique to quantify the amount of 
specific and non-specific antibodies. 
It must be noted that, the comparison of the IgY 
concentration obtained in this work with that obtained by 
other authors may be different due to the influence of 
factors, such as, the variety and concentrations of 
antigens used, as well as the inoculation routes and, type 
of adjuvant. Other factors that may influence the yield of 
IgY in the yolk are the egg yolk weight and the 
percentage hen-day production, which are considered to 
be important factors for the efficient production of IgY (Li 
et al., 1998). Pauly et al. (2009) monitored IgY levels in 
hens over a two-year period and found that although the 
laying capacity in the second year was lower than in the 
first year, the total IgY content was greater and therefore 
compensated for the reduced egg number.  
The in vitro bacterial growth inhibition assay is an 
important investigative tool for evaluating the biological 
activity of alternative anti-microbial agents such as IgY. 
Previous results suggested a potential neutralizing effect 
of IgY preparations in growth inhibition assays (Amaral et 
al., 2008). The present study showed that IgY anti-bovine 
ETEC was able to inhibit the ETEC growth; when the 
concentrations of IgY was high, the time to inhibit the 
bacterial growth was more efficient.  
Similar inhibition values were reported by Mahdavi et 
al. (2010) with chicken egg yolk antibodies against E. coli 
O78:K80.  However,  in  contrast  to  these  authors,  with 
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40 mg/ml of non-specific IgY, a significant inhibitory effect 
on bacterial growth after 6 h of incubation was achieved. 
This growth inhibition effect is due to the fact that we 
found anti-ETEC IgY in purified fractions from non-
immunized chickens. This may have been as a result of 
natural exposure of hens to antigenic components of non-
pathogenic E. coli in the hatchery.  It may be appropriate 
to use purified fimbrial antigens for the immunization of 
animals to obtain polyclonal antibodies. Several studies 
have reported conclusive evidence from trials using 
biochemically pure fimbrial antigens for immunization 
(Cook et al., 2007; Liou et al., 2011). However, most of 
the studies used whole bacterial cells for the 
immunization of hens (Sunwoo et al., 2002; Amaral et al., 
2008; Zhen et al., 2008). 
The sequential isolation of enterocytes appears to be 
an appropriate method to obtain a primary culture with 
low contamination with other types of cells. With the 
addition of epidermal growth factor, these culture 
conditions favor the proliferation of epithelial cells. The 
cell showed a spherical morphology which is typical of 
mid villus and deep crypts (Kaeffer, 2002). Therefore, we 
considered that primary bovine enterocyte culture may be 
used as a tool for the study of intestinal diseases and 
was employed to assess the effects of anti-ETEC IgY on 
ETEC adherence. 
In this study, a low rate of bacterial growth inhibition 
was found. However, anti-ETEC IgY and non-specific IgY 
demonstrated significant reduction of the adherence of 
ETEC F17
+
 to bovine intestinal epithelial cells in vitro. 
Cook et al. (2007) demonstrated that the inhibition of 
adherence was due to the influence of the antibodies on 
specific pathogenic processes and not a result of direct 
inhibition of bacterial growth. Recently, Ma and Zhang 
(2011) found that IgY and Fab’ fragment of egg yolk 
immunoglobulin raised against LPS may be used to 
inhibit and treat tissue injury caused by LPS. ETEC 
develop their pathogenicity by cell attachment, which is a 
prerequisite for intestinal colonization. Such colonization 
is promoted by bacterial adherence to receptor structures 
present on host epithelial surfaces. The effect of non-
specific IgY may be mediated by the innate levels of anti-
E. coli IgY present in non-immunized egg yolks used in 
this study. These antibodies could be due to the natural 
exposure of hens to E. coli and may be sufficient to inhibit 
adherence.  
The results of our study agree with those of Jin et al. 
(1998), who reported that anti-K88
+
 IgY when added to 
K88
+ 
E. coli prevented their binding to receptors in the 
mucus isolated from piglet intestine. Same results were 
obtained by Girard et al. (2006) who demonstrated that 
anti-intimin IgY effectively prevented intimate attachment 
of EPEC and EHEC to porcine ileal in vitro organ culture. 
In concordance, Cook et al. (2007) found that both anti-
EspA and anti-intimin IgY reduced bacterial adhesion and 
largely prevented host cell actin rearrangements. 
Previous studies (Sunwoo et al., 2002; Zhen et al.,  2008) 
 
 
 
 
reported that specific IgY could adhere to bacterial 
surface resulting in structural modifications. These 
alterations could influence bacterial growth and biological 
functionality, such as adherence to cell. 
 
 
Conclusions 
 
Our findings suggest that anti-ETEC IgY can be purified 
with high purity with an economic, simple and rapid 
method such us WD method accompanied with salt 
precipitation. Bovine intestinal cell culture has proved to 
be an excellent tool to study bovine intestinal pathogens 
such as ETEC. The inhibitory effect of specific IgY on 
growth and adherence of ETEC suggests that IgY can be 
considered as a possible treatment for farm animal 
welfare, particularly for protection against gastrointestinal 
infections.  
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